[contentuser]

Experimental Drug for Psoriasis Shows Promise
November 29, 2010

Researchers have announced that a new investigational drug treatment for psoriasis briakinumab, has been shown to be safe and effective in a series of phase III clinical trials, according to a recent statement from the manufacturer, Abbott Laboratories.

In one 52-week study involving 317 people with psoriasis 82% of the participants taking briakinumab had at least a 75% or greater improvement in the severity of their psor...Read the full article